NCT06177925
- Conditions
- Bronchial Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
- Locations
-
- Nanfang Hospital, Southern Medical University Guangzhou, China
Clinical trial condition
Small Cell Lung Carcinoma
Explore clinical trials studying Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.
71 public trials
21 recruiting studies
Small Cell Lung Carcinoma trial results
Not yet recruiting
A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
NCT07623642
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +55 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
Not yet recruiting
Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD
NCT07357532
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
- Locations
-
- Peking University Cancer Hospital & Institute Beijing, China
Not yet recruiting
Adebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer
NCT06236997
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
- Locations
-
- Henan Cancer Hospital Zhengzhou, Henan, China
- Tongji Hospital, Tongji Medical College，Huazhong University of Science and Technology Wuhan, Hubei, China
Not yet recruiting
FASTing-like Approach and Maintenance IMMunotherapy in ES-SCLC Patients Not Progressing on Chemoimmunotherapy Induction
NCT05703997
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
- Locations
-
- Fondazione IRCCS Istituto Nazionale Tumori Milan, Italy
Enrolling by invitation
Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)
NCT06419179
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
- Locations
-
- University Hospital Cologne Cologne, North Rhine-Westphalia, Germany
Active, not recruiting
Durvalumab After Chemoradiotherapy in Limited Stage Small Cell Lung Cancer.
NCT06992609
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
- Locations
-
- Research Site A Coruña, Spain
- Research Site Badajoz, Spain
- Research Site Barakaldo, Spain
- Research Site Barcelona, Spain
Active, not recruiting
An Exploratory Study of Lurbinectedin With Radiotherapy in SCLC With Single-lesion Progression After First Course Treatment
NCT06501976
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
- Locations
-
- National Cancer Center/Cancer Hospital Beijing, China
Active, not recruiting
A French Real-life Study: EvaluatioN of durvALumab Utilization and Effectiveness for First Line Extensive Stage Small Cell Lung Cancer.
NCT05683977
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
- Locations
-
- Research Site Angers, France
- Research Site Argenteuil, France
- Research Site Avignon, France
- Research Site Avignon, France
NCT04938817
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
- Locations
-
- Banner MD Anderson Cancer Center ( Site 0152) Gilbert, Arizona, United States
- Northside Hospital-Northside Hospital Oncology Network ( Site 0156) Atlanta, Georgia, United States
- Parkview Research Center at Parkview Regional Medical Center ( Site 0180) Fort Wayne, Indiana, United States
- Baptist Health Lexington-Research ( Site 0158) Lexington, Kentucky, United States